Cargando…
Effective Amelioration of Liver Fibrosis Through Lentiviral Vector Carrying Toxoplasma gondii gra15(II) in Murine Model
Our previous investigations indicated that in vitro polarization of mouse macrophages by Toxoplasma gondii type (II) strain dense granule protein 15 (GRA15(II)), one of the genotype-associated effectors of T. gondii, induced the phenotypes of classically activated macrophage (M1). Transfusion of the...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043635/ https://www.ncbi.nlm.nih.gov/pubmed/30034399 http://dx.doi.org/10.3389/fimmu.2018.01572 |
_version_ | 1783339322264518656 |
---|---|
author | Liu, Lei Jin, Mengmeng Tao, Qing Yu, Li Du, Jian Wang, Cong Luo, Qingli Xing, Tian Xu, Yuanhong Shen, Jilong Chu, Deyong |
author_facet | Liu, Lei Jin, Mengmeng Tao, Qing Yu, Li Du, Jian Wang, Cong Luo, Qingli Xing, Tian Xu, Yuanhong Shen, Jilong Chu, Deyong |
author_sort | Liu, Lei |
collection | PubMed |
description | Our previous investigations indicated that in vitro polarization of mouse macrophages by Toxoplasma gondii type (II) strain dense granule protein 15 (GRA15(II)), one of the genotype-associated effectors of T. gondii, induced the phenotypes of classically activated macrophage (M1). Transfusion of the cells to mice may effectively alleviated hepatic fibrosis caused by schistosomiasis. The purpose of the study was to identify whether liver macrophages can be in vivo driven to M1 macrophages by lentiviral vector (LV) carrying GRA15(II) gene (LV-gra15(II)) and to explore the potential mechanism by which the LV-gra15(II)-activated liver macrophage (LV-gra15(II)-M) ameliorates the hepatic fibrosis in schistosomiasis. The mice were treated with LV-gra15(II) by hydrodynamic injection via the tail vein followed by challenge of Schistosoma japonicum (S. japonicum). Our experiments showed that LV-gra15(II) was successfully delivered to liver macrophages and GRA15(II) was persistently expressed in the macrophages of mice for at least 2 months. Furthermore, the LV-gra15(II) infected macrophages were polarized to M1 macrophages in vivo. Consequently, mice with schistosomiasis receiving LV-gra15(II) injection displayed a remarkable amelioration of liver granuloma formation and collagen deposition in association with downregulated expression of transforming growth factor-beta1, arginase 1 (Arg-1), α-smooth muscle actin, and an increased expression of matrix metalloproteinase 13 (MMP13). Simultaneously, no negative effects of liver function and vitality of mice were noted. The in vitro experiments indicated that the C-C motif chemokine ligand 2 and nitric oxide level were elevated in LV-gra15(II)-M cultural supernatants; hepatocyte growth factor expression was enhanced in LV-gra15(II)-M. In addition, LV-gra15(II)-M not only secreted MMP13, which greatly degraded type (I) collagen, but also induced murine hepatic stellate cell (HSC) line (JS1) apoptosis in the co-culture system. Taken together, we identified for the first time that LV-gra15(II) may in vivo drive liver macrophages to M1 macrophage phenotypes, which helps for alteration of the liver fibrotic microenvironment with collagen dissolution, HSC deactivation, apoptosis and hepatocyte protection. Our study gives an insight into the use of gene delivery with parasite-derived immunomodulatory factor as a potential immune cell activating agent to re-equilibrate the other pathogen-induced immune response in some chronic diseases. |
format | Online Article Text |
id | pubmed-6043635 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-60436352018-07-20 Effective Amelioration of Liver Fibrosis Through Lentiviral Vector Carrying Toxoplasma gondii gra15(II) in Murine Model Liu, Lei Jin, Mengmeng Tao, Qing Yu, Li Du, Jian Wang, Cong Luo, Qingli Xing, Tian Xu, Yuanhong Shen, Jilong Chu, Deyong Front Immunol Immunology Our previous investigations indicated that in vitro polarization of mouse macrophages by Toxoplasma gondii type (II) strain dense granule protein 15 (GRA15(II)), one of the genotype-associated effectors of T. gondii, induced the phenotypes of classically activated macrophage (M1). Transfusion of the cells to mice may effectively alleviated hepatic fibrosis caused by schistosomiasis. The purpose of the study was to identify whether liver macrophages can be in vivo driven to M1 macrophages by lentiviral vector (LV) carrying GRA15(II) gene (LV-gra15(II)) and to explore the potential mechanism by which the LV-gra15(II)-activated liver macrophage (LV-gra15(II)-M) ameliorates the hepatic fibrosis in schistosomiasis. The mice were treated with LV-gra15(II) by hydrodynamic injection via the tail vein followed by challenge of Schistosoma japonicum (S. japonicum). Our experiments showed that LV-gra15(II) was successfully delivered to liver macrophages and GRA15(II) was persistently expressed in the macrophages of mice for at least 2 months. Furthermore, the LV-gra15(II) infected macrophages were polarized to M1 macrophages in vivo. Consequently, mice with schistosomiasis receiving LV-gra15(II) injection displayed a remarkable amelioration of liver granuloma formation and collagen deposition in association with downregulated expression of transforming growth factor-beta1, arginase 1 (Arg-1), α-smooth muscle actin, and an increased expression of matrix metalloproteinase 13 (MMP13). Simultaneously, no negative effects of liver function and vitality of mice were noted. The in vitro experiments indicated that the C-C motif chemokine ligand 2 and nitric oxide level were elevated in LV-gra15(II)-M cultural supernatants; hepatocyte growth factor expression was enhanced in LV-gra15(II)-M. In addition, LV-gra15(II)-M not only secreted MMP13, which greatly degraded type (I) collagen, but also induced murine hepatic stellate cell (HSC) line (JS1) apoptosis in the co-culture system. Taken together, we identified for the first time that LV-gra15(II) may in vivo drive liver macrophages to M1 macrophage phenotypes, which helps for alteration of the liver fibrotic microenvironment with collagen dissolution, HSC deactivation, apoptosis and hepatocyte protection. Our study gives an insight into the use of gene delivery with parasite-derived immunomodulatory factor as a potential immune cell activating agent to re-equilibrate the other pathogen-induced immune response in some chronic diseases. Frontiers Media S.A. 2018-07-06 /pmc/articles/PMC6043635/ /pubmed/30034399 http://dx.doi.org/10.3389/fimmu.2018.01572 Text en Copyright © 2018 Liu, Jin, Tao, Yu, Du, Wang, Luo, Xing, Xu, Shen and Chu. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Liu, Lei Jin, Mengmeng Tao, Qing Yu, Li Du, Jian Wang, Cong Luo, Qingli Xing, Tian Xu, Yuanhong Shen, Jilong Chu, Deyong Effective Amelioration of Liver Fibrosis Through Lentiviral Vector Carrying Toxoplasma gondii gra15(II) in Murine Model |
title | Effective Amelioration of Liver Fibrosis Through Lentiviral Vector Carrying Toxoplasma gondii gra15(II) in Murine Model |
title_full | Effective Amelioration of Liver Fibrosis Through Lentiviral Vector Carrying Toxoplasma gondii gra15(II) in Murine Model |
title_fullStr | Effective Amelioration of Liver Fibrosis Through Lentiviral Vector Carrying Toxoplasma gondii gra15(II) in Murine Model |
title_full_unstemmed | Effective Amelioration of Liver Fibrosis Through Lentiviral Vector Carrying Toxoplasma gondii gra15(II) in Murine Model |
title_short | Effective Amelioration of Liver Fibrosis Through Lentiviral Vector Carrying Toxoplasma gondii gra15(II) in Murine Model |
title_sort | effective amelioration of liver fibrosis through lentiviral vector carrying toxoplasma gondii gra15(ii) in murine model |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043635/ https://www.ncbi.nlm.nih.gov/pubmed/30034399 http://dx.doi.org/10.3389/fimmu.2018.01572 |
work_keys_str_mv | AT liulei effectiveameliorationofliverfibrosisthroughlentiviralvectorcarryingtoxoplasmagondiigra15iiinmurinemodel AT jinmengmeng effectiveameliorationofliverfibrosisthroughlentiviralvectorcarryingtoxoplasmagondiigra15iiinmurinemodel AT taoqing effectiveameliorationofliverfibrosisthroughlentiviralvectorcarryingtoxoplasmagondiigra15iiinmurinemodel AT yuli effectiveameliorationofliverfibrosisthroughlentiviralvectorcarryingtoxoplasmagondiigra15iiinmurinemodel AT dujian effectiveameliorationofliverfibrosisthroughlentiviralvectorcarryingtoxoplasmagondiigra15iiinmurinemodel AT wangcong effectiveameliorationofliverfibrosisthroughlentiviralvectorcarryingtoxoplasmagondiigra15iiinmurinemodel AT luoqingli effectiveameliorationofliverfibrosisthroughlentiviralvectorcarryingtoxoplasmagondiigra15iiinmurinemodel AT xingtian effectiveameliorationofliverfibrosisthroughlentiviralvectorcarryingtoxoplasmagondiigra15iiinmurinemodel AT xuyuanhong effectiveameliorationofliverfibrosisthroughlentiviralvectorcarryingtoxoplasmagondiigra15iiinmurinemodel AT shenjilong effectiveameliorationofliverfibrosisthroughlentiviralvectorcarryingtoxoplasmagondiigra15iiinmurinemodel AT chudeyong effectiveameliorationofliverfibrosisthroughlentiviralvectorcarryingtoxoplasmagondiigra15iiinmurinemodel |